Mitchell J Melling
Physician in North Creek, UT
License number
Utah 112624-1205
Issued Date
Aug 4, 1998
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
North Creek, UT
Personal information
See more information about Mitchell J Melling at radaris.comName
Address
Phone
2375 Melling Dr, Cedar City, UT 84721
Organization information
See more information about Mitchell J Melling at bizstanding.comMitchell J Melling MD PC
North Creek, UT
Status:
Inactive
Industry:
Medical Doctor's Office
Addresses:
1059 N 100 West St, North Creek, UT 84713
PO Box 850, North Creek, UT 84713
PO Box 850, North Creek, UT 84713
Medical Doctor, Principal:
Mitchell J. Melling (Medical Doctor, Principal)
Professional information
See more information about Mitchell J Melling at trustoria.com
Immunomodulatory Therapeutic Agents
Immunomodulatory Therapeutic Agents
US Patent:
2011031, Dec 29, 2011
Filed:
Mar 9, 2010
Appl. No.:
13/203045
Inventors:
Mitchell J. Melling - Beaver UT, US
Wade M. Melling - Beaver UT, US
Wade M. Melling - Beaver UT, US
International Classification:
A61K 39/00, A61P 37/06, A61K 38/36, C07K 7/06, C07K 7/08
US Classification:
4241851, 530329, 530328, 530327, 530326, 514 136
Abstract:
A group of peptides has been isolated from the serum of domesticated mammals and then identified through the use of mass spectrometry. These peptides are byproducts of fibrinogen activation and the complement cascade. The peptides of greatest activity are the activated forms of fibrinopeptide A and fibrinopeptide B {activated by the removal of the terminal Arginine), and an immunomodulatory fragment of Complement Component 3. These form of fibrinopeptides A and B have remarkable immunomodulatory ability, enhancing recognition of foreign substances including infectious agents of all types, decreasing the inflammatory response, preventing the deposition of extravascular fibrin, stimulating the resorption of fibrin that has already been deposited, enhancing the body's ability to recognize and eliminate neoplastic cells, decreasing symptoms of allergic reaction including allergic rhinitis and anaphylaxis, decrease the formation and deposit of autoantibody complexes, ameliorate the symptoms of chronic neurologic disease, and decrease the symptoms of chronic pain syndromes.